Aquestive Therapeutics Inc (AQST)

Deferred Revenue

$1.09M

Quarterly · Period ending: · USD

AQST logo

AQST Deferred Revenue

Latest reported$1.09M
AQST Quarterly Deferred Revenue ($0.00 → $1.09M)
High-resolution chart · PNG

AQST deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aquestive Therapeutics Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
1,092,000
1,092,000
1,092,000
1,092,000
1,092,000
1,048,000
1,048,000
1,048,000
1,046,000
1,551,000
1,551,000
2,637,000
3,992,000
4,765,000
1,513,000
774,000
1,599,000
1,599,000
765,000
767,000
642,000
437,000
693,000
722,000
803,000
663,000
806,000
835,000
600,000
700,000
721,000
781,000
1,234,000
1,170,000
1,347,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.